OTC Pharmaceuticals - Uganda | Statista Market Forecast

Revenue in the OTC Pharmaceuticals market amounts to US$219.20m in 2024. The market is expected to grow annually by 7.59% (CAGR 2024-2029).
The market's largest segment is the segment Vitamins & Minerals with a market volume of US$92.91m in 2024.
In global comparison, most revenue is generated United States (US$41bn in 2024).
In relation to total population figures, per person revenues of US$4.39 are generated in 2024.
In the OTC Pharmaceuticals market, 0.3% of total revenue will be generated through online sales by 2024.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Uganda is experiencing steady growth due to customer preferences for convenient and accessible healthcare solutions.

Customer preferences: Customers in Uganda prefer over-the-counter (OTC) pharmaceutical products because they offer a convenient and cost-effective way to address common health issues. OTC drugs are easily accessible without a prescription, allowing consumers to self-diagnose and treat minor ailments such as cold and flu symptoms, allergies, and pain relief. The affordability of OTC medications makes them particularly appealing to the majority of the population who cannot afford expensive prescription drugs or doctor consultations.

Trends in the market: One of the key trends in the OTC Pharmaceuticals market in Uganda is the increasing demand for herbal and traditional medicines. Traditional healing practices and herbal remedies have long been a part of Ugandan culture, and many consumers believe in their effectiveness. As a result, there is a growing market for herbal OTC products, including supplements, teas, and topical remedies. This trend is driven by the perception that herbal medicines are more natural and have fewer side effects compared to synthetic drugs. Another trend in the market is the rise of e-commerce and online pharmacies. With the increasing penetration of smartphones and internet connectivity in Uganda, more consumers are turning to online platforms to purchase OTC medications. Online pharmacies offer a wide range of products at competitive prices, and they provide the convenience of home delivery. This trend is particularly popular among urban consumers who have access to the internet and prefer the convenience of online shopping.

Local special circumstances: The OTC Pharmaceuticals market in Uganda faces unique challenges due to the limited healthcare infrastructure and a lack of awareness about the importance of self-care. Many people in rural areas have limited access to healthcare facilities and rely heavily on OTC medications for their healthcare needs. However, there is a need for increased education and awareness campaigns to ensure the safe and responsible use of OTC drugs. Additionally, regulatory bodies need to strengthen their oversight to ensure the quality and safety of OTC products in the market.

Underlying macroeconomic factors: The growth of the OTC Pharmaceuticals market in Uganda is supported by favorable macroeconomic factors. The country has experienced steady economic growth in recent years, leading to an increase in disposable income among the population. This has resulted in higher healthcare spending, including the purchase of OTC medications. Additionally, the government has implemented policies to promote the development of the pharmaceutical sector, which has attracted investment and contributed to market growth. In conclusion, the OTC Pharmaceuticals market in Uganda is driven by customer preferences for convenient and accessible healthcare solutions. The market is characterized by the increasing demand for herbal and traditional medicines, as well as the rise of e-commerce and online pharmacies. However, the market also faces challenges related to limited healthcare infrastructure and a lack of awareness about self-care. The growth of the market is supported by favorable macroeconomic factors, including steady economic growth and government policies to promote the pharmaceutical sector.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Consumer market, in a PDF format.

The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.